OR WAIT null SECS
Clive Glover is strategy director and Mark Szczypka is technical director, cell and gene therapy, both at Pall Corporation.
Clive Glover and Mark Szczypka discuss the complexities of scaling up the manufacturing of gene therapies and gene-modified cell therapies to industrial levels.